February 11, 2008 - The American Society of Echocardiography (ASE) has issued a new consensus statement for interpreting ...
A third round of software enhancements has been made to the iLab System 1.3, an ultrasound imaging system designed to strengthen physician confidence in the diagnosis and intervention of percutaneous coronary intervention (PCI) and increase workflow efficiency.
February 11, 2008 - Boston Scientific Corp. today announced that the first patient has been enrolled in its PROENCY ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
GE's Innova BiPlane cardiovascular imaging system is one of the first digital flat panel biplane systems with a full ...
February 11, 2008 - The first patient was successfully treated in AtriCure’s ABLATE clinical trial designed to evaluate ...
February 11, 2008 - Battlefield Imaging of Ringgold, GA, has become the first facility in the U.S. to install the MAGNETOM ESSENZA magnetic resonance imaging (MRI) system from Siemens Healthcare, designed to be an affordable 1.5 Tesla system.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
February 11, 2008 - Leman Cardiovascular’s animal studies to evaluate the performance in both the aortic and mitral ...
Toshiba’s Cardio Prospective helps reduce patient radiation dose by up to 80 percent during coronary CTA exams by using a helical acquisition technique to provide one continuous image instead of multiple images produced by the current step-and-shoot technique.
February 11, 2008 – Medrad Inc. today said it entered into a definitive merger agreement to acquire Possis Medical Inc., which in combination will offer a broader, more comprehensive suite of products to the cardiovascular intervention field.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
February 8, 2008 - Emageon received first place in the “Best in KLAS” Top 20 Report for the Cardiology PACS nomination ...
February 7, 2008 - Volcano Corp. said the FDA cleared the s5-Revo and s5-FFR (fractional flow reserve) options, enabling ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Emageon's HeartSuite offers cardiovascular information management, hemodynamic monitoring, advanced visualization and content management. Emageon’s architecture combines HeartSuite with radiology and other medical specialties designed to offer a comprehensive patient–centric view of the visual medical record. One suite of integrated, enterprise cardiology tools includes:
February 8, 2008 - CryoLife Inc. received 510(k) clearance from the FDA for its CryoValve SG pulmonary human heart valve processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
February 8, 2008 - The FDA granted Volcano Corp. 510(k) clearance for its s5-Revo and s5-FFR (fractional flow reserve) options, allowing physicians access phased Array IVUS, Rotational IVUS and integrated FFR on the same integrated IVUS platform.
February 10, 2008
